Skip to main content
Equibles

Amundi

Position in RPRX — Royalty Pharma plc

CIK 1330387 Paris, I0
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$208,797,052
+$60,628,612 QoQ
Shares Held
3,723,864
+20.6% QoQ
Ownership
0.648%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#20
of 646 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,267,538 across 70 Biotechnology names. RPRX ranks #3 (8.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,546,509 $768,197,412
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,013,540 $631,982,729
3 RPRX
Royalty Pharma plc
This page 		3,723,864 $208,797,052
4 ALNY
Alnylam Pharmaceuticals, Inc.
 617,471 $185,877,294
5 INCY
Incyte Corp
 1,181,498 $133,934,612
6 TECH
BIO-TECHNE Corp
 1,827,241 $129,094,576
7 MRNA
Moderna, Inc.
 888,779 $62,241,193
8 ARGX
Argenx SE
 65,122 $60,418,237

All Filings in RPRX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $208,797,052 3,723,864
2026-03-31 $148,168,440 3,088,773
2025-12-31 $103,531,203 2,679,379
2025-09-30 $73,029,070 2,069,985
2025-06-30 $100,792,879 2,797,471
2025-03-31 $38,519,572 1,237,378
2024-12-31 $65,152,484 2,553,998
2024-09-30 $104,425,600 3,691,255
2024-06-30 $54,431,949 2,064,162
2024-03-31 $67,070,773 2,208,455
2023-12-31 $103,733,444 3,692,896
2023-09-30 $43,751,168 1,612,055
2023-06-30 $42,185,112 1,372,320
2023-03-31 $37,207,636 1,032,685
2022-12-31 $33,843,658 856,368
2022-12-31 $52,653 133,908
2022-09-30 $33,333,566 829,606
2022-06-30 $39,373,226 936,566
2022-03-31 $11,687,100 299,977
2021-12-31 $7,958,958 199,723
2021-09-30 $50,353,173 1,393,281
2021-06-30 $115,930,577 2,828,265